Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11524 posts found.

medicinal_cannabis_uk_review

UK Government call for more research into medicinal cannabis

July 4, 2019 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CBMP, Marijuana, UK, medicinal cannabis, pharma, politics

The British government has called for more research into cannabis-based medicinal products (CBMPs). In a paper published on 3 July, …
News
landing-hero-images1

ViiV’s Dovato approved in Europe as treatment option for HIV-1

July 3, 2019 Research and Development, Sales and Marketing Dovato, GSK, HIV, ViiV Healthcare, pharma

ViiV Healthcare, the specialist HIV firm majority owned by GSK, is celebrating the news that the European Commission has chosen …
News

US Government awarded new patent on preventative HIV drugs PrEP

July 3, 2019 Research and Development, Sales and Marketing Gilead, HHS, government, pharma

The Department of Health and Human Services (HHS) has been awarded a new patent on drugs that prevent HIV. The …
News

Roche’s Tecentriq scores CHMP recommendation in PD-L1+ metastatic triple-negative breast cancer

July 2, 2019 Manufacturing and Production, Research and Development, Sales and Marketing Roche, breast cancer, pharma, tecentriq

Roche’s immunotherapy Tecentriq (atezolizumab) has been recommended by the EMA’s Committee for Medicinal Products for Human Use (CHMP) in combination …
News
shutterstock_158366573

Libtayo becomes first EU-approved therapy for advanced cutaneous squamous cell carcinoma

July 2, 2019 Manufacturing and Production, Sales and Marketing Europe, Libtayo, Regeneron, Sanofi, carcinoma, pharma

The European Commission has revealed that it has decided to award approval, albeit conditionally, to Sanofi and Regeneron’s Libtayo (cemiplimab) …
News

Living with mal de debarquement syndrome

July 1, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing patient experience, pharma, rare disease

Polly Moyer reflects on her experiences living with the rare condition mal de debarquement syndrome, and discusses how connecting with …
Feature
janssen_latest_logo_on_sign

Janssen secures two positive CHMP opinions for Imbruvica label expansions

July 1, 2019 Sales and Marketing CHMP, EMA, Europe, Janssen, imbruvica, pharma

Janssen’s Imbruvica (ibrutinib) has racked up two positive recommendations from the European Medicines Agency’s Committee for Medicinal Products for Human …
News
novartis_window

Novartis says it did not send substances for chemical weapons to Syria

July 1, 2019 Sales and Marketing Brenntag, Novartis, Syria, chemical weapons, pharma, war

Swiss firm Novartis has said that it did not send chemicals that could be used to make chemical weapons to …
News

FDA greenlights Pfizer biosimilar version of Genentech’s Avastin

July 1, 2019 Sales and Marketing Cancer, Genentech, Pfizer, pharma, pncology

Pfizer is celebrating the approval by the FDA of Zirabev, its biosimilar version of Genentech’s Avastin (bevacizumab), which is now …
News

Pfizer’s Revatio flops in Phase 3 trial

July 1, 2019 Sales and Marketing

American multinational Pfizer has said that Revatio (Sildenafil Citrate) in combination with nitric oxide, has failed to meet its primary …
News
medical-supplies-paper-bag

Medicines recalled after FMD alert

July 1, 2019 Sales and Marketing FMD, MHRA, labels, pharma, recall, supply chain

The MHRA has warned patients that batches of drugs for Parkinson’s, epilepsy and blood clots have been taken out of …
News
julyaugust_2019_cover

Read the July/August edition of Pharmafocus online now!

June 28, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing NHS, Orkambi, Trump, UK, brexit, generics, manufacturing compliance, pharma

The latest monthly edition of Pharmafocus, the July/August issue, is available to read for free online now!The UK remains split …
News
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

June 28, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AbbVie, Allergan, Bristol-Myers Squibb, China, GSK, Novartis, Takeda, brexit

This week was diverse as always in terms of news coming out of the pharma industry, but the biggest news …
News
janssen_latest_logo_on_sign

Janssen’s Darzalex combo approved by FDA in transplant-ineligible multiple myeloma patients

June 28, 2019 Medical Communications, Sales and Marketing Janssen, darzalex, mutiple myeloma, pharma

Janssen’s Darzalex (daratumumab) has secured FDA approval in combination with lenalidomide and dexamethasone for the treatment of newly diagnosed multiple …
News
shutterstock_158366573

Healthcare communications: Time to think differently with patient centricity

June 27, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Spink, patient centricity, pharma

Patient centricity, derived from the NHS-driven thinking “no decision about me, without me”, has been adopted by pharma to understand …
Feature
The Gateway to Local Adoption Series

Latest content

Siemens Healthineers opens 10m euro R&D centre for laboratory equipment in Ireland

February 19, 2026

Everdrone announces new board of directors to drive expansion

February 19, 2026

Regeneron announces presentations of new data on Eylea HD for retinal disease

February 18, 2026

Indegene completes acquisition of Cake Health

February 18, 2026

Gedeon Richter UK acquires rights to schizophrenia treatment Reagila from Recordati Pharmaceuticals

February 17, 2026